Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Evaluation of the Synergy of Ceftazidime-Avibactam in combination with Meropenem, Amikacin, Aztreonam, Colistin and Fosfomycin Against Well Characterized Multi-Drug Resistant K. pneumoniae and P. aeruginosa.

Mikhail S, Singh NB, Kebriaei R, Rice SA, Stamper KC, Castanheira M, Rybak MJ.

Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00779-19. doi: 10.1128/AAC.00779-19. [Epub ahead of print]

PMID:
31182535
2.

Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis/oralis in an Ex Vivo Simulated Endocarditis Vegetation Model.

Kebriaei R, Rice SA, Stamper KC, Seepersaud R, Garcia-de-la-Maria C, Mishra NN, Miro JM, Arias CA, Tran TT, Sullam PM, Bayer AS, Rybak MJ.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00386-19. doi: 10.1128/AAC.00386-19. Print 2019 Jun.

PMID:
30962347
3.

Teaching an Old Class New Tricks: A Novel Semi-Synthetic Aminoglycoside, Plazomicin.

Abdul-Mutakabbir JC, Kebriaei R, Jorgensen SCJ, Rybak MJ.

Infect Dis Ther. 2019 Jun;8(2):155-170. doi: 10.1007/s40121-019-0239-0. Epub 2019 Mar 9. Review.

4.

Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of Staphylococcus aureus in a Simulated Pharmacodynamic/Pharmacokinetic Model.

Kebriaei R, Rice SA, Stamper KC, Rybak MJ.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e01743-18. doi: 10.1128/AAC.01743-18. Print 2019 Apr.

PMID:
30670436
5.

Evaluation of dalbavancin alone and in combination with β-lactam antibiotics against resistant phenotypes of Staphylococcus aureus.

Xhemali X, Smith JR, Kebriaei R, Rice SA, Stamper KC, Compton M, Singh NB, Jahanbakhsh S, Rybak MJ.

J Antimicrob Chemother. 2019 Jan 1;74(1):82-86. doi: 10.1093/jac/dky376.

PMID:
30260409
6.

Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSA.

Bhise K, Sau S, Kebriaei R, Rice SA, Stamper KC, Alsaab HO, Rybak MJ, Iyer AK.

Materials (Basel). 2018 Jul 20;11(7). pii: E1245. doi: 10.3390/ma11071245.

7.

Influence of Inoculum Effect on the Efficacy of Daptomycin Monotherapy and in Combination with β-Lactams against Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions.

Kebriaei R, Rice SA, Singh KV, Stamper KC, Dinh AQ, Rios R, Diaz L, Murray BE, Munita JM, Tran TT, Arias CA, Rybak MJ.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00315-18. doi: 10.1128/AAC.00315-18. Print 2018 Aug.

8.

Combination of Tedizolid and Daptomycin against Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations.

Smith JR, Yim J, Rice S, Stamper K, Kebriaei R, Rybak MJ.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e00101-18. doi: 10.1128/AAC.00101-18. Print 2018 May.

9.

Evaluation of Salivary and Serum Antioxidant and Oxidative Stress Statuses in Patients with Chronic Periodontitis: A Case-Control Study.

Ahmadi-Motamayel F, Goodarzi MT, Jamshidi Z, Kebriaei R.

Front Physiol. 2017 Mar 31;8:189. doi: 10.3389/fphys.2017.00189. eCollection 2017.

Supplemental Content

Loading ...
Support Center